https://www.gene.com/ Genentech is a pioneering biotechnology company that has been at the forefront of the industry for over four decades. Founded in 1976 by venture capitalist Robert A. Swanson and biochemist Dr. Herbert W. Boyer, Genentech is widely regarded as the world's first biotechnology company[4][5]. ## Company Overview Genentech is headquartered in South San Francisco, California, and has been a wholly-owned subsidiary of the Swiss pharmaceutical company Roche Group since 2009[4]. As of July 2021, the company employed 13,539 people[4]. Genentech's mission is to pursue groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases[6]. ## Scientific Breakthroughs Genentech's founders recognized the potential of recombinant DNA technology to create beneficial new products[5]. The company has since made several significant contributions to the field of biotechnology: - Developed the first targeted antibody for cancer[3] - Created the first medicine for primary progressive multiple sclerosis[3] - Pioneered the use of recombinant DNA technology to produce commercial medicines[5] ## Key Products and Innovations Over the years, Genentech has developed numerous innovative medicines across various therapeutic areas. Some notable products include: - Herceptin (trastuzumab): For HER2-positive breast cancer[7] - Lucentis (ranibizumab): For neovascular age-related macular degeneration[4] - Tecentriq (atezolizumab): An immunotherapy for various types of cancer[4] - Ocrevus (ocrelizumab): For multiple sclerosis[7] ## Recent Developments Genentech continues to innovate and expand its product portfolio. Recent FDA approvals and developments include: - Itovebi (inavolisib): Approved in October 2024 for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation[7] - Ocrevus Zunovo: A subcutaneous injection approved in September 2024 for multiple sclerosis[7] - PiaSky (crovalimab-akkz): Approved in June 2024 for paroxysmal nocturnal hemoglobinuria[7] ## Impact on Biotechnology Genentech's success has played a crucial role in shaping the modern biotechnology industry. The company's ability to translate scientific discoveries into commercial products has inspired countless other biotech ventures and contributed to the growth of the sector as a whole[8]. Today, Genentech remains committed to following the science and seeking solutions to unmet medical needs, continuing its legacy as a trailblazer in the field of biotechnology[6]. Citations: [1] https://www.gene.com/about-us [2] https://www.gene.com/patients/medicines [3] https://www.roche.com/innovation/structure/genentech [4] https://en.wikipedia.org/wiki/Genentech [5] https://www.gene.com/about-us/leadership/our-founders [6] https://www.genentech-pro.com/about-us.html [7] https://www.drugs.com/manufacturer/genentech-inc-57.html [8] https://www.labiotech.eu/in-depth/history-biotechnology-genentech/ [9] https://app.dealroom.co/companies/genentech [10] https://www.zippia.com/genentech-careers-24406/history/